A high-content screening of anti-cancer compounds suggests the multiple tyrosine kinase inhibitor ponatinib for repurposing in neuroblastoma therapy.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Alessandro Quattrone Michela Croce Luca Longo Gian Paolo Tonini Sanja Aveic Luigi Pasini Marianna Avitabile Viktoryia Sidarovich |
| Publication date | April 25, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |